NEPC LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
PF
NEPC LLC's XBI Position: Q3 2023 in Review
NEPC LLC sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2023, closing a stake of 1,500 shares — an estimated $125K sold.
NEPC LLC first reported a position in XBI in Q2 2021 and held it in 2 quarters. The position peaked at $609K in Q2 2021. 679 funds tracked by Wall St. Rank hold XBI as of Q3 2023.
- NEPC LLC reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2023 after selling out during the quarter.
- NEPC LLC sold 1,500 State Street SPDR S&P Biotech ETF shares in Q3 2023, an estimated $125K.
- NEPC LLC first reported a position in State Street SPDR S&P Biotech ETF in Q2 2021 and held it in 2 quarters.
- NEPC LLC's State Street SPDR S&P Biotech ETF position peaked at $609K in Q2 2021.
- 679 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2023.
Based on NEPC LLC's 13F filing for Q3 2023, filed 8 Mar 2024.